These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20845463)

  • 1. In vitro and in vivo lung deposition of coated magnetic aerosol particles.
    Xie Y; Longest PW; Xu YH; Wang JP; Wiedmann TS
    J Pharm Sci; 2010 Nov; 99(11):4658-68. PubMed ID: 20845463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
    Martin AR; Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
    McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
    Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic deposition of aerosols composed of aggregated superparamagnetic nanoparticles.
    Xie Y; Zeng P; Siegel RA; Wiedmann TS; Hammer BE; Longest PW
    Pharm Res; 2010 May; 27(5):855-65. PubMed ID: 20198407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting magnetic retention of particles in the upper airways: an in vitro and ex vivo study.
    Ally J; Amirfazli A; Roa W
    J Aerosol Med; 2006; 19(4):491-509. PubMed ID: 17196078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-throat.
    Zhang Y; Finlay WH
    J Aerosol Med; 2005; 18(4):460-73. PubMed ID: 16379621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of magnetic aerosol droplets to the lung.
    Dames P; Gleich B; Flemmer A; Hajek K; Seidl N; Wiekhorst F; Eberbeck D; Bittmann I; Bergemann C; Weyh T; Trahms L; Rosenecker J; Rudolph C
    Nat Nanotechnol; 2007 Aug; 2(8):495-9. PubMed ID: 18654347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats.
    Creutzenberg O; Bellmann B; Korolewitz R; Koch W; Mangelsdorf I; Tillmann T; Schaudien D
    Inhal Toxicol; 2012 Oct; 24(12):821-30. PubMed ID: 23033995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
    Tewes F; Ehrhardt C; Healy AM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.
    Ahmed A; Prime D; Burnell PK; Högger P
    J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):169-78. PubMed ID: 22280010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle deposition in the lung of the Göttingen minipig.
    Windt H; Kock H; Runge F; Hübel U; Koch W
    Inhal Toxicol; 2010 Aug; 22(10):828-34. PubMed ID: 20513165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical simulation of in-vitro dispersion and deposition of nanoparticles in dry-powder-inhaler aerosols.
    Mendes PJ; Pinto JF; Sousa JM
    J Nanosci Nanotechnol; 2010 Apr; 10(4):2791-7. PubMed ID: 20355503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary distribution of deposited particles.
    Brand P; Häussinger K; Meyer T; Scheuch G; Schulz H; Selzer T; Heyder J
    J Aerosol Med; 1999; 12(4):275-84. PubMed ID: 10724642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats.
    Asgharian B; Kelly JT; Tewksbury EW
    Toxicol Sci; 2003 Jan; 71(1):104-11. PubMed ID: 12520080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies of particle distribution range of aerosol cromolyn sodium generated by MDI systems].
    Gradoń L; Sosnowski TR
    Pol Merkur Lekarski; 1999 May; 6(35):253-5. PubMed ID: 10437393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition Mechanisms.
    Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):181-185. PubMed ID: 32598200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition.
    Schmid O; Bolle I; Harder V; Karg E; Takenaka S; Schulz H; Ferron GA
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):291-307. PubMed ID: 18627243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.